After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KNSA belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Kiniksa Pharmaceuticals International Plc is $1.44B. A total of 0.45 million shares were traded on the day, compared to an average of 322.56K shares.
In the most recent transaction, Tessari Eben sold 23,017 shares of KNSA for 20.44 per share on Dec 16 ’24. After the transaction, the CHIEF OPERATING OFFICER now owns 95,975 company shares. In a previous transaction on Dec 16 ’24, Tessari Eben bought 23,017 shares at 20.44 per share.
Among the insiders who sold shares, Ragosa Mark disposed of 18,860 shares on Dec 09 ’24 at a per-share price of $21.38. This resulted in the CHIEF FINANCIAL OFFICER holding 22,958 shares of KNSA after the transaction. In another insider transaction, Ragosa Mark sold 8,969 shares at $21.27 per share on Dec 06 ’24. Company shares held by the CHIEF FINANCIAL OFFICER now total 22,958.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KNSA has a high of $28.15 and a low of $16.56.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KNSA’s latest balance sheet shows that the firm has $182.20M in Cash & Short Term Investments as of fiscal 2021. There were $6.05M in debt and $44.82M in liabilities at the time. Its Book Value Per Share was $6.06, while its Total Shareholder’s Equity was $185.04M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KNSA is Buy with a score of 5.00.
